Keppra IV for the Treatment of Motor Fluctuations in Parkinson's Disease Trial Phase 4 Withdrawn Nov. 15, 2021
Clinical Characteristics of Parkinson's Disease Subjects With Severe Hypertension During Motor OFFs. Trial N/A Suspended Nov. 15, 2021
Pilot Study to Evaluate the Self-Management of Gait, Speech, and Dexterity Symptoms in Parkinson's Disease Using a Smartphone Application Trial N/A Unknown Nov. 14, 2021
Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease Trial Phase 4 Completed Nov. 8, 2021
Parallel-Group Study to Assess the Effect of Rasagiline on Cognition in Patients With Parkinson's Disease Trial Phase 4 Completed Nov. 8, 2021
Trial of Ursodeoxycholic Acid (UDCA) for Parkinson's Disease: The "UP" Study Trial Phase 2 Completed Nov. 7, 2021
Multicenter Study of Blood Biomarkers of Mitochondrial and Peroxisomal Metabolism to Differentiate Idiopathic Parkinson's Disease From Related Conditions Trial N/A Unknown Nov. 7, 2021
Does N-Acetylcysteine Decrease Spontaneous Oxidation of Central Neural Dopamine in Parkinson's Disease? Trial Phase 1 Terminated Nov. 3, 2021
Effect of Medical Cannabis for Non-motor Symptoms of Parkinson's Disease Trial N/A Unknown Nov. 2, 2021
A Study of the Efficacy and Safety of Carbidopa-Levodopa Extended-Release Tablets in Patients With Parkinson's Disease Trial Phase 2 Unknown Oct. 31, 2021
Modafinil for Freezing of Gait (FOG) in Parkinson's Disease (PD) Trial Phase 2 Completed Oct. 26, 2021
Genetic Influences on Response to Gait Rehabilitation in Parkinson's Disease Trial N/A Completed Oct. 26, 2021
The Effect of Cervical Spinal Stabilization Exercises in Patients With Parkinson's Disease Trial N/A Completed Oct. 25, 2021
Trial Comparing Functional Outcomes of Awake vs. Asleep Deep Brain Stimulation (DBS) for Parkinson's Disease Trial N/A Terminated Oct. 25, 2021
The Acute Effect of Lumbosacral Mobilization in Parkinson's Disease Trial N/A Completed Oct. 20, 2021
The Therapeutic Effect of Transcranial Direct Current Stimulation on Depression in Parkinson's Disease Trial Phase 1 Terminated Oct. 19, 2021